I agree that this site is using cookies. You can find further informations here.
X
Hirsh, Vera
114  results:
Search for persons X
?
1

Transitioning to Neoadjuvant Therapy for Resectable Non-Sma..:

Pilon, Yohann ; Rokah, Merav ; Seitlinger, Joseph...
Clinical Lung Cancer.  25 (2024)  3 - p. e133-e144.e4 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Radiogenomic Models Using Machine Learning Techniques to Pr..:

Nair, Jay Kumar Raghavan ; Saeed, Umar Abid ; McDougall, Connor C....
Canadian Association of Radiologists Journal.  72 (2020)  1 - p. 109-119 , 2020
Link: https://doi.org/10.1177/..
 
?
3

Optimal sequencing strategies in the treatment of EGFR muta..:

Hirsh, Vera ; Singh, Jaspal
American Journal of Health-System Pharmacy.  77 (2020)  18 - p. 1466-1476 , 2020
Link: https://doi.org/10.1093/..
 
?
4

A Randomized, Double-Blind, Placebo-Controlled, Phase III N..:

Gascón, Pere ; Nagarkar, Rajnish ; Šmakal, Martin...
Journal of Thoracic Oncology.  15 (2020)  2 - p. 190-202 , 2020
Link: https://doi.org/10.1016/..
 
?
5

First-line afatinib for advanced EGFRm+ NSCLC: Analysis of ..:

Schuler, Martin ; Paz-Ares, Luis ; Sequist, Lecia V....
Lung Cancer.  133 (2019)  - p. 10-19 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Amplifying Outcomes: Checkpoint Inhibitor Combinations in F..:

Melosky, Barbara ; Juergens, Rosalyn ; Hirsh, Vera...
The Oncologist.  25 (2019)  1 - p. 64-77 , 2019
Link: https://doi.org/10.1634/..
 
?
7

First-line afatinib vs gefitinib for patients with EGFR mut..:

Schuler, Martin ; Tan, Eng-Huat ; O'Byrne, Kenneth...
Journal of Cancer Research and Clinical Oncology.  145 (2019)  6 - p. 1569-1579 , 2019
Link: https://doi.org/10.1007/..
 
?
8

Sequencing of therapy following first-line afatinib in pati..:

Park, Keunchil ; Bennouna, Jaafar ; Boyer, Michael...
Lung Cancer.  132 (2019)  - p. 126-131 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Quality-adjusted Outcomes Stratified by Response in Patient..:

Hirsh, Vera ; Wan, Yin ; Lin, Fang-Ju...
Clinical Lung Cancer.  19 (2018)  5 - p. 401-409.e4 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Turning EGFR mutation-positive non-small-cell lung cancer i..:

Hirsh, Vera
Therapeutic Advances in Medical Oncology.  10 (2018)  - p. 175883401775333 , 2018
Link: https://doi.org/10.1177/..
 
?
11

Afatinib as First-line Treatment of Older Patients WithEGFR..:

Wu, Yi-Long ; Sequist, Lecia V. ; Tan, Eng-Huat...
Clinical Lung Cancer.  19 (2018)  4 - p. e465-e479 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Retrospective Assessment of a Serum Proteomic Test in a Pha..:

Buttigliero, Consuelo ; Shepherd, Frances A. ; Barlesi, Fabrice...
The Oncologist.  24 (2018)  6 - p. e251-e259 , 2018
Link: https://doi.org/10.1634/..
 
?
13

Symptom and Quality of Life Improvement in LUX-Lung 8, an O..:

Felip, Enriqueta ; Hirsh, Vera ; Popat, Sanjay...
Clinical Lung Cancer.  19 (2018)  1 - p. 74-83.e11 , 2018
Link: https://doi.org/10.1016/..
 
?
14

P3.02b-023 Physician Patterns of Care in Patients with EGFR..:

Tischer, Bernd ; Kim, Edward ; Peters, Matthew.
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1199-S1200 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Perspectives in immunotherapy: meeting report from the "Imm..:

Ascierto, Paolo A. ; Daniele, Bruno ; Hammers, Hans...
Journal of Translational Medicine.  15 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
1-15